Webinar Launch 7th of July 2020 on the outsourcing of Flow Cytometry R&D activities.

Outsourcing R&D for Advanced Therapies – Flow Cytometry Ever increasing proportions of research & development activities are conducted by contract-research-organizations (CROs) on behalf of biotech and pharma companies.

Outsourcing R&D for Advanced Therapies – Flow Cytometry

Ever increasing proportions of research & development activities are conducted by contract-research-organizations (CROs) on behalf of biotech and pharma companies. However, how is subcontracted flow cytometry managed for Advanced Therapy Medicinal Products (ATMPs). This event sets out to provide insight to industry on practical applications from two immunology CROs on offering standardized and custom-tailored flow cytometry solutions. A high-level view of the scientific approach and the regulatory aspect will be presented and discussed.

Program

  • 15:00: Check-in and Welcome, Per Spindler, Biopeople, Denmark
  • 15:10-15:35: CRO support for pre-clinical and clinical Biopharmaceutical development. Meeting regulatory requirements through an understanding of immune responses by flow cytometry. Chris Rothwell, Covance, United Kingdom
  • 15:35-15:50: Contract flow cytometry for pre-clinical and clinical exploratory endpoints to assess mode-of-action and immunotoxicology. Houman Pourhassan, ImmuMap, Denmark
  • 15:50-16:30: The chat will be open and the presenters will answer questions and discuss as appropriate.

 

Would you like to participate in the event?

You are welcome! It is free, but registration is mandatory at biopeople.eu.